FDA.reportPublic FDA data

Olopatadine Hydrochloride Ophthalmic Solution

Manufacturer
Rugby Laboratories
Effective date
2026-03-27
Label type
Human OTC Drug Label
Version
6
Source
full-release
Hydrated at
2026-06-01 01:51:54

Label at a glance#

ProductOlopatadine Hydrochloride Ophthalmic Solution
Active ingredientOLOPATADINE HYDROCHLORIDE
Label structure15 sections

Indications and uses

temporarily relieves itchy and red eyes due to pollen, ragweed, grass, animal hair and dander

Dosage and administration

• adults and children 2 years of age and older: • put 1 drop in the affected eye(s) twice daily, every 6 to 8 hours, no more than twice per day • if using other ophthalmic products while using this product, wait at least 5 minutes between each product • replace cap after each use   • children under 2 years of age: consult a doctor

Label contents#

Full prescribing information#

SPL PRODUCT DATA ELEMENTS SECTION

SPL UNCLASSIFIED SECTION

ACTIVE INGREDIENT

OTC - ACTIVE INGREDIENT SECTION

Olopatadine (0.1%) (equivalent to olopatadine hydrochloride 0.111%)

PURPOSE

OTC - PURPOSE SECTION

Antihistamine and redness reliever


USES

INDICATIONS & USAGE SECTION

temporarily relieves itchy and red eyes due to pollen, ragweed, grass, animal hair and dander

WARNINGS

WARNINGS SECTION

For external use only

DO NOT USE

OTC - DO NOT USE SECTION

• if solution changes color or becomes cloudy 
• if you are sensitive to any ingredient in this product
• to treat contact lens related irritation

WHEN USING THIS PRODUCT

OTC - WHEN USING SECTION

  • do not touch tip of container to any surface to avoid contamination
  • remove contact lenses before use
  • wait at least 10 minutes before reinserting contact lenses after use
  • do not wear a contact lens if your eye is red

STOP USE AND ASK DOCTOR IF

OTC - STOP USE SECTION

you experience:  

  • eye pain
  • changes in vision
  • increased redness of the eye
  • itching worsens or lasts for more than 72 hours

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

DIRECTIONS

DOSAGE & ADMINISTRATION SECTION

• adults and children 2 years of age and older:
• put 1 drop in the affected eye(s) twice daily, every 6 to 8 hours, no more than twice per day
• if using other ophthalmic products while using this product, wait at least 5 minutes between each product
• replace cap after each use  
• children under 2 years of age: consult a doctor

OTHER INFORMATION

OTHER SAFETY INFORMATION

• only for use in the eye  
• store between 4° to 25°C (39° to 77°F)

INACTIVE INGREDIENTS

INACTIVE INGREDIENT SECTION

Benzalkonium chloride 0.01%, Dibasic sodium phosphate, Hydrochloric acid and /or Sodium hydroxide (to adjust pH), Sodium chloride and Water for Injection.

QUESTIONS?

OTC - QUESTIONS SECTION

Call 1-888-375-3784

SPL UNCLASSIFIED SECTION

Distributed by:

RUGBY® LABORATORIES

Indianapolis, IN 46268

(800) 616-2471

www.major-rugby.com

Made in India

Rev. 08/20

R-145 Re-order No. 371044

*This product is not manufactured or distributed by Alcon Laboratories Inc., distributor of Pataday® Twice Daily Relief . Pataday® is a registered trademark of Novartis AG.

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 0536-1308-40

NOW AVAILABLE without a prescription

Twice Daily Relief

Olopatadine HCl

Ophthalmic Solution, USP, 0.1%

Antihistamine and Redness Reliever

Works in Minutes

Relief from Allergens:

• pet dander

• pollen

• grass

• ragweed

Twice Daily

Sterile

5 mL

Compare to active ingredient in Pataday Twice Daily Relief*

Packaged with Tamper-Evident bottle cap. Do Not Use if breakable ring is separated or missing.

For Ages 2 and Older

30 DAY SUPPLY

Carton
Carton

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1111339olopatadine HCl 0.1 % Ophthalmic SolutionPSN6
1111339olopatadine 1 MG/ML Ophthalmic SolutionSCD6
1111339olopatadine 0.1 % Ophthalmic SolutionSY6
1111339olopatadine 1 MG/ML (as olopatadine HCl 1.11 MG/ML) Ophthalmic SolutionSY6

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
OLOPATADINE Pharmacologic Class Indexing4Indexing - Pharmacologic Class20220128

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
624001e0-0eba-4aac-a60c-c2ecb37d4f08Product name120220927
abab02bf-82c6-4b6c-8cb4-2ee39055aeb1Product name320210312
ee1438f7-d464-b7de-1b3a-aae378f7d672Product name820200121
4101b788-a943-3f81-6947-4acf7be2af4dProduct name420190703
ca2d4a1a-2b5b-4256-9aad-735e9282b3eeProduct name120150323

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0536-1308-40Olopatadine Hydrochloride Ophthalmic Solution1 in 1 CARTONSOLUTION/ DROPS16
0536-1308-40Olopatadine Hydrochloride Ophthalmic Solution5 mL in 1 BOTTLE, PLASTICSOLUTION/ DROPS56

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0536-1308-40ML - Milliliter0536-13088c84710f-1a68-4670-a3a2-7f6dcc353cab12021-03-02

Products#

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
0536-13080536-1308-40

Ingredients#

Name, UNII, Kind table
NameUNIIKind
OLOPATADINE HYDROCHLORIDE2XG66W44KFACTIM
BENZALKONIUM CHLORIDEF5UM2KM3W7IACT
SODIUM PHOSPHATE, DIBASICGR686LBA74IACT
HYDROCHLORIC ACIDQTT17582CBIACT
SODIUM CHLORIDE451W47IQ8XIACT
SODIUM HYDROXIDE55X04QC32IIACT
WATER059QF0KO0RIACT

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
42025-12-10monthly-update2026-06-03 17:45:53

Orange Book products#

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A209619-001OLOPATADINE HYDROCHLORIDEOLOPATADINE HYDROCHLORIDEEQ 0.1% BASESOLUTION/DROPS / OPHTHALMIC2019-08-02

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
9d39e5da-cb1e-a420-e72b-c6d297bd880fd7bcba63-bfaf-240b-199e-2e42a91c19c92026-03-27WarningsExact identifier

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

warnings

WARNINGS For external use only